JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marcus, F. I.
Right arrow Articles by Feinberg, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marcus, F. I.
Right arrow Articles by Feinberg, J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 159, Issue 2, 314-323, 1968
Copyright © 1968 by American Society for Pharmacology and Experimental Therapeutics


THE EFFECT OF RESERPINE ON THE METABOLISM OF TRITIATED DIGOXIN IN THE DOG AND IN MAN

Frank I. Marcus 1, Josee Pavlovich 1, Muriel Lullin 1, Geeta Kapadia 1, Jay Scully 1, Sheik Hassan 1, and Jack Feinberg 1

1 The Georgetown University Medical Division, District of Columbia General Hospital, Washington, D. C.

Pharmacologic response to digitalis appears to be diminished in the reserpine-pretreated mammalian heart. A lower myocardial concentration of digitalis was postulated to account for the decrease in inotropic response in the reserpine-treated animals. Five dogs were injected i.p. on 2 successive days with 0.1 mg/kg of reserpine. There were six control dogs. All of the animals were given 0.5 mg of tritiated digoxin i.v. and were sacrificed 1 hr later. The concentration of digoxin and metabolites in the heart and spleen was significantly less in reserpine-treated dogs as compared with the controls. In contrast, the renal tissue concentration and urinary excretion of digoxin were greater in the reserpine-treated animals. Increased urinary excretion of digoxin in the reserpine group could not account for the decrease in myocardial concentration of digoxin, since there was also a lower myocardial concentration in reserpine-treated nephrectomized dogs as compared with nephrectomized, untreated controls. No change in digoxin metabolism could be established in normal human subjects after 6 weeks of daily administration of reserpine p.o. in usual clinical doses. A lower myocardial concentration of digoxin in reserpine-treated animals may explain the observed diminished inotropic response to digitalis. These studies provide the first evidence that other pharmacologic agents may be determinants of the myocardial concentration of cardiac glycosides.

Submitted on June 21, 1967
Accepted on October 24, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics.